对于患有与PRRT2相关的自限婴儿的患者来说, levetiracetam 可能是不合适的选择
Yang Tian1,2, Zhen Shi2, Jiahao Cai2
1The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
BMC pediatrics
|October 25, 2023
概括
列维对治疗由PRRT2突变引起的自我限制的婴儿 (SeLIE) 无效. 其他抗发作药物 (ASM) 对SELIE发作缓解非常有效.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 自限性婴儿 (SeLIE) 是一种一般良性综合征.
- 大多数抗发作药物 (ASM) 作为单一治疗SeLIE有效.
- 在SELIE中, levetiracetam的疗效之前没有被研究过.
研究的目的:
- 调查 levetiracetam 在治疗具有PRRT2突变的SeLIE患者中的疗效.
- 为了在这个患者群体中比较 levetiracetam 与其他ASM 的有效性.
主要方法:
- 对39名患有PRRT2或16p11.2微切除的SELIE患者的临床数据的回顾性分析.
- 根据最初的ASM,患者被分为两组:莱维他拉塞坦组 (LEG) 和其他ASM组 (OAG).
- 在LEG和OAG之间的效率比较.
主要成果:
- 该LEG显示了低的发作缓解率 (12.50%),大多数患者经历了无效或恶化.
- 相比之下,OAG证明了高缓解率 (95.65%).
- 从 levetiracetam 转换为其他ASM导致13名14名患者的发作控制.
结论:
- 列维对具有PRRT2突变的SELIE患者没有好处.
- 替代性ASM在获得PRRT2突变的SELIE患者的缓解方面是有效的.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Seizures: Classification
378
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
378
Arteries of the Lower Limbs
194
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
194
Antiepileptic Drugs: Potassium Channel Activators
192
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
192
Antiepileptic Drugs: Glutamate Antagonists
383
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
383
Antiepileptic Drugs: GABAergic Pathway Potentiators
425
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
425


